174 related articles for article (PubMed ID: 37126546)
1. Abrogation of MAP4K4 protein function causes congenital anomalies in humans and zebrafish.
Patterson V; Ullah F; Bryant L; Griffin JN; Sidhu A; Saliganan S; Blaile M; Saenz MS; Smith R; Ellingwood S; Grange DK; Hu X; Mireguli M; Luo Y; Shen Y; Mulhern M; Zackai E; Ritter A; Izumi K; Hoefele J; Wagner M; Riedhammer KM; Seitz B; Robin NH; Goodloe D; Mignot C; Keren B; Cox H; Jarvis J; Hempel M; Gibson CF; Tran Mau-Them F; Vitobello A; Bruel AL; Sorlin A; Mehta S; Raymond FL; Gilmore K; Powell BC; Weck K; Li C; Vulto-van Silfhout AT; Giacomini T; Mancardi MM; Accogli A; Salpietro V; Zara F; Vora NL; Davis EE; Burdine R; Bhoj E
Sci Adv; 2023 Apr; 9(17):eade0631. PubMed ID: 37126546
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase.
Machida N; Umikawa M; Takei K; Sakima N; Myagmar BE; Taira K; Uezato H; Ogawa Y; Kariya K
J Biol Chem; 2004 Apr; 279(16):15711-4. PubMed ID: 14966141
[TBL] [Abstract][Full Text] [Related]
3. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
Bouzakri K; Zierath JR
J Biol Chem; 2007 Mar; 282(11):7783-9. PubMed ID: 17227768
[TBL] [Abstract][Full Text] [Related]
4. MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
Fuller SJ; Edmunds NS; McGuffin LJ; Hardyman MA; Cull JJ; Alharbi HO; Meijles DN; Sugden PH; Clerk A
Biochem J; 2021 Jun; 478(11):2121-2143. PubMed ID: 34032269
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Is Critical for Lymphatic Vascular Development and Function.
Roth Flach RJ; Guo CA; Danai LV; Yawe JC; Gujja S; Edwards YJ; Czech MP
Mol Cell Biol; 2016 Jun; 36(12):1740-9. PubMed ID: 27044870
[TBL] [Abstract][Full Text] [Related]
6. Map4k4 negatively regulates peroxisome proliferator-activated receptor (PPAR) gamma protein translation by suppressing the mammalian target of rapamycin (mTOR) signaling pathway in cultured adipocytes.
Guntur KV; Guilherme A; Xue L; Chawla A; Czech MP
J Biol Chem; 2010 Feb; 285(9):6595-603. PubMed ID: 20038583
[TBL] [Abstract][Full Text] [Related]
7. MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
Gao X; Chen G; Gao C; Zhang DH; Kuan SF; Stabile LP; Liu G; Hu J
Mol Oncol; 2017 Jun; 11(6):628-639. PubMed ID: 28306189
[TBL] [Abstract][Full Text] [Related]
8. Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype-phenotype relationship in RASopathies.
Yoon JG; Yu JW; Shim KW; Kim YO; Lee MG
Clin Genet; 2024 Aug; 106(2):199-203. PubMed ID: 38679877
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.
Tesz GJ; Guilherme A; Guntur KV; Hubbard AC; Tang X; Chawla A; Czech MP
J Biol Chem; 2007 Jul; 282(27):19302-12. PubMed ID: 17500068
[TBL] [Abstract][Full Text] [Related]
10. MAP4K4 Is a Threonine Kinase That Phosphorylates FARP1.
Schwaid AG; Su C; Loos P; Wu J; Nguyen C; Stone KL; Kanyo J; Geoghegan KF; Bhattacharya SK; Dow RL; Buckbinder L; Carpino PA
ACS Chem Biol; 2015 Dec; 10(12):2667-71. PubMed ID: 26422651
[TBL] [Abstract][Full Text] [Related]
11. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling.
Danai LV; Guilherme A; Guntur KV; Straubhaar J; Nicoloro SM; Czech MP
J Lipid Res; 2013 Oct; 54(10):2697-707. PubMed ID: 23924694
[TBL] [Abstract][Full Text] [Related]
12. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis.
Wu C; Watts ME; Rubin LL
Cell Rep; 2019 Jan; 26(5):1143-1156.e5. PubMed ID: 30699345
[TBL] [Abstract][Full Text] [Related]
13. RBM4a-SRSF3-MAP4K4 Splicing Cascade Constitutes a Molecular Mechanism for Regulating Brown Adipogenesis.
Peng HY; Liang YC; Tan TH; Chuang HC; Lin YJ; Lin JC
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200638
[TBL] [Abstract][Full Text] [Related]
14. Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases.
Virbasius JV; Czech MP
Trends Endocrinol Metab; 2016 Jul; 27(7):484-492. PubMed ID: 27160798
[TBL] [Abstract][Full Text] [Related]
15. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport.
Tang X; Guilherme A; Chakladar A; Powelka AM; Konda S; Virbasius JV; Nicoloro SM; Straubhaar J; Czech MP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2087-92. PubMed ID: 16461467
[TBL] [Abstract][Full Text] [Related]
16. Integrated exome and transcriptome analysis prioritizes MAP4K4 de novo frameshift variants in autism spectrum disorder as a novel disease-gene association.
Cesana M; Vaccaro L; Larsen MJ; Kibæk M; Micale L; Riccardo S; Annunziata P; Colantuono C; Di Filippo L; De Brasi D; Castori M; Fagerberg C; Acquaviva F; Cacchiarelli D
Hum Genet; 2023 Mar; 142(3):343-350. PubMed ID: 36469137
[TBL] [Abstract][Full Text] [Related]
17. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
18. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.
Collins CS; Hong J; Sapinoso L; Zhou Y; Liu Z; Micklash K; Schultz PG; Hampton GM
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3775-80. PubMed ID: 16537454
[TBL] [Abstract][Full Text] [Related]
19. MAP4K4 negatively regulates CD8 T cell-mediated antitumor and antiviral immunity.
Esen E; Sergin I; Jesudason R; Himmels P; Webster JD; Zhang H; Xu M; Piskol R; McNamara E; Gould S; Capietto AH; Delamarre L; Walsh K; Ye W
Sci Immunol; 2020 Mar; 5(45):. PubMed ID: 32220977
[TBL] [Abstract][Full Text] [Related]
20. Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation.
Wang M; Amano SU; Flach RJ; Chawla A; Aouadi M; Czech MP
Mol Cell Biol; 2013 Feb; 33(4):678-87. PubMed ID: 23207904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
